Skip to content

Clinical trials

Phase 1 Chronic Limb-Threatening Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20094
20111
20141
20153
20161
20172
20183
20192
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status5
Recruiting2
Terminated2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pluristem Ltd.2
Ageless Regenerative Institute1
Allife Medical Science and Technology Co., Ltd.1
Aplagon Oy1
Arteriocyte, Inc.1
Boston Medical Center1
Helixmith Co., Ltd.1
Instituto de Molestias Cardiovasculares1
Libella Gene Therapeutics1
Losordo, Douglas, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia27
Peripheral Arterial Disease8
Peripheral Vascular Diseases7
Leg Ulcer2
Vascular Diseases2
Arterial Occlusive Diseases1
Constriction, Pathologic1
Diabetes Mellitus1
Gangrene1
Intermittent Claudication1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.